ArticleProceedings of the National Academy of Sciences of the United States of America2018

C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.

Yang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.